Statistics for Vir Biotechnology (id:7439 VIR)

Valuation metrics

Market cap

1.10B

Enterprise value

301.48M

Trailing P/E (ttm)

-1.55

Forward P/E

-2.14

PEG ratio

-2.14

Price/Sales (ttm)

14.03

Price/Book (mrq)

0.88

Enterprise Value/Revenue

3.84

Enterprise Value/EBITDA

-0.56

Overview

Shares outstanding

137.72M

Float

92.51M

Shares short

5.72M

% Held by insiders

0.12%

% Held by institutions

0.74%

Average volume (10 days)

1.15M

Average volume (90 days)

Price summary

52-Week low

6.56

52-Week high

13.09

52-Week change

-33.43%

Beta

0.46

50-Day moving average

8.00

200-Day moving average

9.20

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

93.00%

Operating margin

-9,184.54%

Operational effectiveness

Return on assets

-19.41%

Return on equity

-36.58%

Income statement

Revenue (ttm)

0.58

Revenue per share (ttm)

0.58

Quarterly revenue growth (yoy)

Gross profit (ttm)

36.73M

EBITDA

-533,936,992.00

Net income to common (ttm)

-533,344,000.00

Diluted EPS (ttm)

-3.93

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

914.47M

Total cash per share (mrq)

6.64

Total debt (mrq)

112.81M

Total Debt/Equity (mrq)

9.09

Current ratio (mrq)

893.80%

Book value per share (mrq)

9.08

Cash flow

Cash flow statement

-466,644,000.00

Levered free cash flow (LFCF)

-356,994,624.00